FIP1L1::PDGFRA fusion driving three synchronous haematological malignancies

Pathology. 2023 Dec;55(7):1040-1044. doi: 10.1016/j.pathol.2023.05.011. Epub 2023 Jul 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Hypereosinophilic Syndrome*
  • Imatinib Mesylate
  • Oncogene Proteins, Fusion / genetics
  • Receptor Protein-Tyrosine Kinases
  • Receptor, Platelet-Derived Growth Factor alpha / genetics
  • Transcription Factors

Substances

  • Imatinib Mesylate
  • Transcription Factors
  • Receptor Protein-Tyrosine Kinases
  • Receptor, Platelet-Derived Growth Factor alpha
  • Oncogene Proteins, Fusion